NCCN Webinar Series – Treatment Options for Richter Transformation of Chronic Lymphocytic Leukemia
NCCN will host a specialized program titled “Optimizing Patient Outcomes – When Prognosis Changes from Good to Poor: Treatment Options for Richter Transformation of Chronic Lymphocytic Leukemia” on May 6, 2026, from 3:00 PM to 4:00 PM EDT.
Because conventional chemotherapy often yields poor responses in Richter transformation (RT), this session focuses on the critical role of novel therapies, including BTK and BCL-2 inhibitors, immune checkpoint inhibitors, and CAR T-cell therapies. Oncology professionals will gain insights into identifying risk factors and interpreting clinical trial data for emerging treatments, with a strong emphasis on how increased clinical trial awareness can help overcome the limited historical data available for this aggressive transformation.